Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours Β· Estimated delivery Aug 6 - Aug 11
If needed, we may request recent lab work to get a clear picture of your metabolic health before starting
Age (Dordr) 28(3):235253
Trial Structure Duration: 48 weeks of treatment Participants: 338 adults randomized 2:1:1:1:1:2:2 to placebo or retatrutide groups Doses tested: 1mg, 4mg, 8mg, 12mg (all with slow titration from 2mg starting dose) Lifestyle intervention: All participants received counseling on diet (500 kcal/day deficit) and exercise (150 min/week) Primary endpoint: Percent weight change at 24 weeks Key secondary endpoints: Weight change at 48 weeks, proportion achieving 5%, 10%, 15% loss The trial used a slow titration protocol to minimize side effects: all groups except the 1mg dose started at 2mg weekly and escalated every 4 weeks
23 overall pick
Similar results are seen with another BET inhibitor, JQ1, suggesting that this family of proteins may be promising therapeutic targets (191)
US$ 20.82
US$ 27.27
US$ 29.46
US$ 27.81
US$ 20.58
US$ 28.39
